| |
HIV-positive (n=15) |
HIV-negative (N=13) |
| Clinical features |
|
|
| Median age [years] (range) |
42 (26-65) |
46 (19-78) |
| Male |
11 (73%) |
10 (77%) |
| Symptomatic preceding infection |
10 (67%) |
8 (62%) |
| Median MRC sum score at nadir (range) |
32 (12-54) |
38 (2-54) |
| Median GBS disability grade at nadir (range) |
4 (3-5) |
4 (2-5) |
| Median arm grade at nadir (range) |
2 (1-3) |
2 (1-4) |
| Mean time to nadir in days (range) |
10 (2-19) |
9 (2-27) |
| Laboratory features |
|
|
| Demyelinating neuropathy (AIDP) |
11 (73%) |
10 (77%) |
| Serum hyponatraemia (<135 mmol/l) |
9 (60%) |
2 (18%) |
| Mean CSF protein [g/l] (range) |
1.49(0.42-2.69) [n=13] |
1.26 (0.39-5.84) [n=11] |
| CSF lymphocytosis (>5 cells / mm3) |
5 (38%) [n=13] |
2 (18%) [n=11] |
